Bonesupport Holding AB (publ) (2B4.F)
EUR 28.02
(-1.06%)
EUR 28.02
(-1.06%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.56 Million SEK | 0.4% |
| 2022 | 1.55 Million SEK | -24.96% |
| 2021 | 2.07 Million SEK | 98.96% |
| 2020 | 1.04 Million SEK | 5.53% |
| 2019 | 988.31 Thousand SEK | 0.0% |
| 2018 | - EUR | -100.0% |
| 2017 | 10.03 Million EUR | -12.38% |
| 2016 | 11.44 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | - SEK | -2.63% |
| 2024 Q1 | 1.44 Million SEK | -4.83% |
| 2024 Q2 | 15.39 Million EUR | -7.49% |
| 2023 Q3 | 1.12 Million SEK | -12.61% |
| 2023 Q4 | 1.56 Million SEK | 39.14% |
| 2023 FY | 1.56 Million SEK | 0.4% |
| 2023 Q2 | 1.28 Million SEK | -11.31% |
| 2023 Q1 | 1.44 Million SEK | -6.91% |
| 2022 Q4 | 1.55 Million SEK | -7.74% |
| 2022 Q1 | 2.09 Million EUR | 1.05% |
| 2022 Q2 | 1.84 Million EUR | -12.01% |
| 2022 Q3 | 1.68 Million EUR | -8.52% |
| 2021 Q4 | 2.07 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 72.33 Million EUR | 97.838% |
| Carl Zeiss Meditec AG | 155.69 Million EUR | 98.996% |
| Fielmann Aktiengesellschaft | 652.37 Million EUR | 99.76% |
| Gerresheimer AG | 1.04 Billion EUR | 99.85% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 99.971% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 99.971% |